184 related articles for article (PubMed ID: 18640802)
41. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.
Brianzoni E; Rossi G; Ancidei S; Berbellini A; Capoccetti F; Cidda C; D'Avenia P; Fattori S; Montini GC; Valentini G; Proietti A; Algranati C
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1392-9. PubMed ID: 16133395
[TBL] [Abstract][Full Text] [Related]
42. Interesting image. Extrapulmonary small cell carcinoma in prostate: detection with F-18 FDG PET/CT.
Sayed MH; Farghaly HR; Nguyen NC; Mostafa MS; Mekkawy MA; Osman MM
Clin Nucl Med; 2010 Jan; 35(1):38-9. PubMed ID: 20026974
[No Abstract] [Full Text] [Related]
43. Imaging of tumor viability in lung cancer: initial results using 23Na-MRI.
Henzler T; Konstandin S; Schmid-Bindert G; Apfaltrer P; Haneder S; Wenz F; Schad L; Manegold C; Schoenberg SO; Fink C
Rofo; 2012 Apr; 184(4):340-4. PubMed ID: 22351502
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer.
Yi CA; Lee KS; Kim BT; Shim SS; Chung MJ; Sung YM; Jeong SY
AJR Am J Roentgenol; 2007 Feb; 188(2):318-25. PubMed ID: 17242237
[TBL] [Abstract][Full Text] [Related]
45. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
[No Abstract] [Full Text] [Related]
46. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
Eschmann SM; Bitzer M; Paulsen F; Friedel G; Besenfelder H; Horger M; Reimold M; Dittmann H; Pfannenberg AC; Bares R
Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
[TBL] [Abstract][Full Text] [Related]
47. Interesting image. Ameboma mimicking lung cancer on FDG PET/CT.
Yapar AF; Reyhan M; Canpolat ET
Clin Nucl Med; 2010 Jan; 35(1):55-6. PubMed ID: 20026982
[No Abstract] [Full Text] [Related]
48. Interesting image. Two primary colon cancers shown on FDG PET/CT performed to evaluate possible lung metastases from bladder cancer.
Cui R; Li F; Zhuang H
Clin Nucl Med; 2010 Jan; 35(1):53-4. PubMed ID: 20026981
[No Abstract] [Full Text] [Related]
49. 18F-FDG PET/CT in the evaluation of adrenal masses.
Metser U; Miller E; Lerman H; Lievshitz G; Avital S; Even-Sapir E
J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
[TBL] [Abstract][Full Text] [Related]
50. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens.
Wanet M; Lee JA; Weynand B; De Bast M; Poncelet A; Lacroix V; Coche E; Grégoire V; Geets X
Radiother Oncol; 2011 Jan; 98(1):117-25. PubMed ID: 21074882
[TBL] [Abstract][Full Text] [Related]
51. Three synchronous primary tumors with different histology detected by ¹⁸F-FDG PET/CT.
Eren MS; Ozdogan O; Koyuncuoglu M; Degirmenci B
Hell J Nucl Med; 2012; 15(1):56-8. PubMed ID: 22413115
[TBL] [Abstract][Full Text] [Related]
52. PET/CT today and tomorrow.
Townsend DW; Carney JP; Yap JT; Hall NC
J Nucl Med; 2004 Jan; 45 Suppl 1():4S-14S. PubMed ID: 14736831
[TBL] [Abstract][Full Text] [Related]
53. In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.
Zegers CM; van Elmpt W; Reymen B; Even AJ; Troost EG; Ollers MC; Hoebers FJ; Houben RM; Eriksson J; Windhorst AD; Mottaghy FM; De Ruysscher D; Lambin P
Clin Cancer Res; 2014 Dec; 20(24):6389-97. PubMed ID: 25316821
[TBL] [Abstract][Full Text] [Related]
54. Improvement in clinical evaluation of PET/CT images with high resolution algorithms.
Orlandini LC; Betti M; Fulcheri C; Dona M; Fisicaro D; Castagnoli A
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):201-6. PubMed ID: 23486348
[TBL] [Abstract][Full Text] [Related]
55. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT.
Slomka PJ; Dey D; Przetak C; Aladl UE; Baum RP
J Nucl Med; 2003 Jul; 44(7):1156-67. PubMed ID: 12843232
[TBL] [Abstract][Full Text] [Related]
56. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Tsai CC; Tsai CS; Ng KK; Lai CH; Hsueh S; Kao PF; Chang TC; Hong JH; Yen TC
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
[TBL] [Abstract][Full Text] [Related]
57. Lung cancer associated with cystic airspaces.
Mascalchi M; Attinà D; Bertelli E; Falchini M; Vella A; Pegna AL; Ambrosini V; Zompatori M
J Comput Assist Tomogr; 2015; 39(1):102-8. PubMed ID: 25279848
[TBL] [Abstract][Full Text] [Related]
58. Measurements of tumor size using CT and PET compared to histopathological size in non-small cell lung cancer.
Aydin F; Dertsiz L; Budak ES; Yildiz A; Ozbilim G; Gungor F
Diagn Interv Radiol; 2013; 19(4):271-8. PubMed ID: 23302288
[TBL] [Abstract][Full Text] [Related]
59. Incidental findings on integrated PET/CT that do not accumulate 18F-FDG.
Bruzzi JF; Truong MT; Marom EM; Mawlawi O; Podoloff DA; Macapinlac HA; Munden RF
AJR Am J Roentgenol; 2006 Oct; 187(4):1116-23. PubMed ID: 16985164
[TBL] [Abstract][Full Text] [Related]
60. Enhancing 18F-FDG-PET/CT analysis in lung cancer patients. Is CT-CT image fusion helpful in predicting pleural involvement? A pilot study.
Kapfhammer A; Winkens T; Lesser T; Reissig A; Steinert M; Freesmeyer M
Nuklearmedizin; 2015; 54(6):247-54. PubMed ID: 26462554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
